Pivotal Research Initiates Coverage On Herbalife, Sees $150 To $200 Price Long-Term


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Pivotal Research Group initiated coverage of Herbalife Ltd. (NYSE: HLF) with a Buy rating and price target of $110.

Analyst Timothy S. Ramey commented that over the long-term he saw potential for the stock to trade at $150 to $200.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Ramey believed "that a combination of the negative spin from Ackman and the tighter controls on the business that the company has initiated in response to his criticism has very likely slowed growth."

Regarding issues with the FTC, the "Herbalife business model today is, in our opinion, above reproach...It may well be in Herbalife’s interest to accept a fine or sanction from the FTC over sins of the past," according to Ramey.

The report concluded that "it looks like [Herbalife] will generate EBITDA of just over $1 billion next year so it is that exceedingly rare combination of low EV/EBITDA (5.2x currently) and growth with a clean balance sheet."

Ramey valued "HLF on a P/E basis with a "tainted" valuation of only 15x EPS – a ridiculously low value for a company that has consistently grown top-line and EPS in double-digit rates."

Herbalife Ltd. recently traded at $46.42, up 2.18 percent.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorPrice TargetInitiationAnalyst RatingsPivotal Research GroupTimothy S. Ramey